Quest Diagnostics Inc

Healthcare
$128.44
+2.53(2.01%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$126.52$125.911,557,641889,467

Fundamentals

Market Cap$13.93B
P/B Ratio2.2
P/E Ratio16.3
Enterprise Value$18.62B
Div. Yield2.38%
Book Value57.37
EPS(TTM)6.80
ROE12.40%
Understand Fundamentals

About the Company

Headquartered in Secaucus, New Jersey, Quest Diagnostics Inc. is a clinical laboratory. It has an approximate 47,000 employees working in its operations located across Ireland, India, Mexico and the United States. As of 2020, it has over 2,250 physician offices and around 6,600 patient access points in the US. The company owns 23 aircraft and 3,700 courier vehicles, alongside employing over 600 PhDs and MDs in its workforce. It offers four categories of products and services pertaining to clinical trials testing, wellness & risk management, healthcare IT and diagnostic testing services. The company provides testing services for 27 types of medical conditions such as Arthritis, Genetics, HIV, Autoimmune Diseases, Neurology, Toxicology, Lymphoma, Lung Cancer, Paediatrics, General Health, Cardiovascular, Infectious Diseases, Celiac Disease etc. Quest focuses primarily on 17 types of medical specialists like Pulmonologist, Gastroenterologist, Maternal Foetal Medicine Practitioners, Rheumatologists, Dermatologists, Oncologists, Perinatologist, etc. As of 2020, its products are used by 130 countries from across the globe. Quest Diagnostics offers its services to three categories of clients - patients, physicians & hospitals and organisations & companies. The company owns eight brands under it, named - AmriPath, Quest Diagnostics, ExamOne, Quantum Solutions, Athena Diagnostics, Quest HealthConnect, Dermpath Diagnostics and Quest Diagnostics Nichols Institute. Nicolas Institute performs specialised tests for laboratories and hospitals in 26 countries like Mexico, Peru, New Zealand, Taiwan, Chile, Japan, Peru, Australia, France, Panama etc. Quest Diagnostics is one of the Fortune 500 companies and also a component in the S&P 500 list. It trades in the New York Stock Exchange under the ticker symbol DGX share. The company was founded in 1967 as Metropolitan Pathology Laboratory, Inc. by Paul A. Brown, MD. After two years its name changed to MetPath which was then changed to Corning Clinical Laboratories in 1982 after Corning Glass Works acquired it. By the end of 1996, Quest Diagnostics separated from Corning and became an independent company. From 2001 to 2020, it underwent 16 significant acquisitions like Memorial Hermann Health System’s outreach laboratory service business in 2020, Boyce & Bynum Pathology Laboratories’ clinical laboratory services business in 2019, Cleveland HeartLab, Inc. in 2017 and Summit Health, Inc. in 2014.;
OrganisationQuest Diagnostics Inc
IndustryDiagnostics & Research
HeadQuartersSecaucus, NJ

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Invest the way you want
Join millions of Indians who trust and love Groww
Explore Products
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ